VirexpR proposes innovative technological offers and a wider range of R&D services in the field of Indoor Air Quality (IAQ). Spin-off of the academic research laboratory #VirPath (Université Claude Bernard Lyon 1, EZUS Lyon), VirexpR is specialized in the generation of atmospheres contaminated by complex mixtures of infectious pathogens in test stands dedicated to the experimental performance evaluation of air treatment and respiratory protection technologies and devices. An offer of in situ sampling and analysis of indoor air is also offered by VirexpR for a large panel of respiratory pathogenic viruses.
In synergy with several of its providers and industrial partners in the Auvergne-Rhône-Alpes region, France, VirexpR mobilizes its expertise, technologies, and logistics in BSL-2 and BSL-3 facilities within the Lyonbiopole innovation center. This offer will be at the service of establishments open to the public (ERP), communities and manufacturers, in order to contribute to better control of respiratory viral pathogens and more generally to better indoor air quality, with major health, economic and societal implications and challenges.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Chez Lyonbiopôle, Bâtiment Domilyon, 321 Avenue Jean Jaurès,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.virexpr.fr
- Keywords
- de la Qualité de l'air intérieur.
- HQ
- Lyon
Virexpr Questions
Virexpr's website is http://www.virexpr.fr
Virexpr's LinkedIn profile is https://fr.linkedin.com/company/virexpr
Virexpr has
10 employees.
View email and phone details for 10
employees at Virexpr.
Virexpr's industry is
Biotechnology Research
Virexpr's top competitors are
Reventus Pharma,
Mabdesign,
Imebio,
Adjuvatis,
Maat Pharma,
Vaxxel,
Virnext,
Aspida,
Montréal Accueil,
Life Ingénierie & Constructions.
Virexpr's categories are Biotechnology Research
Virexpr's founding year is 2022
